1. OP0061 Kineret® (Anakinra) Controls Disease Symptoms in Patients with Severe Cryopyrin-Associated Periodic Syndromes (CAPS): Up to 5-Year Follow-Up Data. (23rd January 2014) Authors: Olivecrona, H.; Aldén Raboisson, M.; Söderberg, K.; Hallén, B.; Leinonen, M.; Sibley, C.; Plass, N.; Brewer, C.; King, K.; Zalewski, C.; Kim, J.; Bishop, R.; Hill, S.; Paul, S.; Stone, D.; Chapelle, D.; Butman, J.; Goldbach-Mansky, R. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A70 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. SAT0440 The IL-1RA Antagonist Kineret® (Anakinra) Stabilizes Hearing Loss in Patients with Severe Cryopyrin-Associated Periodic Syndromes (CAPS). (23rd January 2014) Authors: Leinonen, M.; Söderberg, K.; Olivecrona, H.; Aldén Raboisson, M.; Sibley, C.; Brewer, C.; Plass, N.; King, K.; Zalewski, C.; Kim, J.; Stone, D.; Chapelle, D.; Goldbach-Mansky, R. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A730 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. THU0402 Efficacy and safety of canakinumab in patients with NOMID/CINCA. (23rd January 2014) Authors: Goldbach-Mansky, R.; Sibley, C.; Felix, S.D.; Brewer, C.; King, K.; Zalewski, C.; Kim, H.J.; Bishop, R.; Chakraborty, A.; Colin, L.; Chioato, A. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 291 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗